class name | count |
---|---|
asterids | 19 |
rosids | 6 |
eudicotyledons | 3 |
Liliopsida | 1 |
Euphyllophyta | 1 |
Embryophyta | 1 |
class name | count |
---|---|
Solanaceae | 10 |
Fabaceae | 6 |
Cornaceae | 5 |
Amaranthaceae | 1 |
Asteraceae | 1 |
Scrophulariaceae | 1 |
Berberidaceae | 1 |
Arecaceae | 1 |
Convolvulaceae | 1 |
Apocynaceae | 1 |
Equisetaceae | 1 |
Lycopodiaceae | 1 |
Crassulaceae | 1 |
br08003 Category | # of metabolite |
---|---|
Pyridine alkaloids | 5 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Pyridine alkaloids | C06180 | C00002015 |
Pyridine alkaloids | C10126 | C00002017 |
Pyridine alkaloids | C00745 | C00002057 |
Pyridine alkaloids | C11360 | C00002061 |
Pyridine alkaloids | C06524 | C00042792 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00002015
![]() |
(-)-Anabasine
|
CHEMBL280963
CHEMBL1496898 CHEMBL1526229 |
D000691
|
15 / 18 / 15 | 0 / 4 |
![]() |
C00002017
![]() |
Anatabine
|
C012737
|
0 / 1 |
![]() |
||
C00002057
![]() |
Nicotine
|
CHEMBL3
CHEMBL9732 CHEMBL440464 CHEMBL1628647 |
D009538
|
131 / 72 / 55 | 370 / 191 |
![]() |
C00002061
![]() |
(+)-Nornicotine
|
CHEMBL6200
CHEMBL264213 CHEMBL1132 |
4 / 2 / 1 |
![]() |
||
C00042792
![]() |
Nornicotine
/ (-)-Nornicotine |
CHEMBL6200
CHEMBL264213 CHEMBL1132 |
4 / 2 / 1 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002015 C00002057 C00002061 C00042792 | 0 / 0 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002015 C00002057 C00002061 C00042792 | 1 / 1 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002015 C00002057 C00002061 C00042792 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002057 C00002061 C00042792 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002015 C00002057 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002015 C00002057 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002015 C00002057 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002015 C00002057 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002015 C00002057 | 0 / 1 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002057 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002057 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002057 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00002015 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002057 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002057 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002057 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002057 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002057 | 2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00002057 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002057 | 11 / 10 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002057 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002057 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002057 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002057 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002057 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002057 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002057 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002057 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002057 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002057 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002057 | 2 / 2 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002057 | 0 / 0 |
Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002057 | 3 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002057 | 0 / 3 |
P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002057 | 2 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002057 | 0 / 0 |
P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002057 | 3 / 2 |
P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002057 | 2 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002057 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002057 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002057 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002057 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002057 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002057 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002057 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002057 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002057 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002057 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002057 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002057 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002057 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002015 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002057 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002057 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00002057 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002057 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002057 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002057 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002057 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002057 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00002057 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002057 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002057 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002057 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002057 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00002057 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002057 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002057 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002057 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002057 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00002057 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002057 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00002015 | 7 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002057 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00002057 | 1 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002057 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002057 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002057 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002057 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002057 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002057 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002057 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002057 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002057 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002057 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002057 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002057 | 2 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002057 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002057 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002057 | 2 / 1 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00002057 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002057 | 1 / 1 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00002057 | 1 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002057 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002057 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002057 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002057 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002057 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002057 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00002057 | 2 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002057 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002057 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002057 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002057 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002057 | 0 / 0 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00002057 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00002057 | 1 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002057 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002015 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002057 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002057 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002057 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002057 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002057 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002057 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002057 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002015 | 4 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002057 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00002015 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002015 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002057 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002057 | 1 / 4 |
Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002057 | 1 / 1 |
Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00002057 | 1 / 1 |
O76082 | Solute carrier family 22 member 5 | Unclassified protein | C00002057 | 1 / 2 |
Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00002057 | 0 / 0 |
Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00002057 | 0 / 0 |
O95264 | 5-hydroxytryptamine receptor 3B | NS | C00002057 | 0 / 0 |
A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00002057 | 0 / 0 |
Q05901 | Neuronal acetylcholine receptor subunit beta-3 | CHRN beta | C00002057 | 0 / 0 |
P30532 | Neuronal acetylcholine receptor subunit alpha-5 | CHRN alpha | C00002057 | 1 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002057 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
9625 | AATK, AATYK, AATYK1, LMR1, LMTK1, p35BP | apoptosis-associated tyrosine kinase (EC:2.7.11.1) |
C00002057
|
1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) |
C00002057
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00002057
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00002057
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002057
|
210 | ALAD, ALADH, PBGS | aminolevulinate dehydratase (EC:4.2.1.24) |
C00002057
|
216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00002057
|
240 | ALOX5, 5-LO, 5-LOX, 5LPG, LOG5 | arachidonate 5-lipoxygenase (EC:1.13.11.34) |
C00002057
|
262 | AMD1, ADOMETDC, AMD, SAMDC | adenosylmethionine decarboxylase 1 (EC:4.1.1.50) |
C00002057
|
269 | AMHR2, AMHR, MISR2, MISRII, MRII | anti-Mullerian hormone receptor, type II (EC:2.7.11.30) |
C00002057
|
327 | APEH, AARE, ACPH, APH, D3F15S2, D3S48E, DNF15S2, OPH | acylaminoacyl-peptide hydrolase (EC:3.4.19.1) |
C00002057
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002057
|
55082 | ARGLU1 | arginine and glutamate rich 1 |
C00002057
|
8874 | ARHGEF7, BETA-PIX, COOL-1, COOL1, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB | Rho guanine nucleotide exchange factor (GEF) 7 |
C00002057
|
408 | ARRB1, ARB1, ARR1 | arrestin, beta 1 |
C00002057
|
546 | ATRX, ATR2, JMS, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX | alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12) |
C00002057
|
572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00002057
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002057
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002057
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00002057
|
627 | BDNF, ANON2, BULN2 | brain-derived neurotrophic factor |
C00002057
|
632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00002057
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002057
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00002057
|
648 | BMI1, FLVI2/BMI1, PCGF4, RNF51 | BMI1 polycomb ring finger oncogene |
C00002057
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00002057
|
689 | BTF3, BETA-NAC, BTF3a, BTF3b, NACB | basic transcription factor 3 |
C00002057
|
695 | BTK, AGMX1, AT, ATK, BPK, IMD1, PSCTK1, XLA | Bruton agammaglobulinemia tyrosine kinase (EC:2.7.10.2) |
C00002057
|
728 | C5AR1, C5A, C5AR, C5R1, CD88 | complement component 5a receptor 1 |
C00002057
|
730 | C7 | complement component 7 |
C00002057
|
811 | CALR, CRT, RO, SSA, cC1qR | calreticulin |
C00002057
|
830 | CAPZA2, CAPPA2, CAPZ | capping protein (actin filament) muscle Z-line, alpha 2 |
C00002057
|
9607 | CARTPT, CART | CART prepropeptide |
C00002057
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00002057
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002057
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002057
|
867 | CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55 | Cbl proto-oncogene, E3 ubiquitin protein ligase |
C00002057
|
11335 | CBX3, HECH, HP1-GAMMA, HP1Hs-gamma | chromobox homolog 3 |
C00002057
|
6360 | CCL16, CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC, Mtn-1, NCC-4, NCC4, SCYA16, SCYL4 | chemokine (C-C motif) ligand 16 |
C00002057
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002057
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002057
|
891 | CCNB1, CCNB | cyclin B1 |
C00002057
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002057
|
894 | CCND2, KIAK0002 | cyclin D2 |
C00002057
|
898 | CCNE1, CCNE | cyclin E1 |
C00002057
|
901 | CCNG2 | cyclin G2 |
C00002057
|
1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00002057
|
1235 | CCR6, BN-1, C-C_CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22 | chemokine (C-C motif) receptor 6 |
C00002057
|
9973 | CCS | copper chaperone for superoxide dismutase |
C00002057
|
920 | CD4, CD4mut | CD4 molecule |
C00002057
|
4179 | CD46, AHUS2, MCP, MIC10, TLX, TRA2.10 | CD46 molecule, complement regulatory protein |
C00002057
|
966 | CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20 | CD59 molecule, complement regulatory protein |
C00002057
|
993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00002057
|
990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00002057
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002057
|
8621 | CDK13, CDC2L, CDC2L5, CHED, hCDK13 | cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22) |
C00002057
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002057
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00002057
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002057
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002057
|
1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta |
C00002057
|
1062 | CENPE, CENP-E, KIF10, PPP1R61 | centromere protein E, 312kDa |
C00002057
|
1106 | CHD2, EEOC | chromodomain helicase DNA binding protein 2 (EC:3.6.4.12) |
C00002057
|
1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00002057
|
1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
C00002057
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00002057
|
1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00002057
|
8973 | CHRNA6, CHNRA6 | cholinergic receptor, nicotinic, alpha 6 (neuronal) |
C00002057
|
1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00002057
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00002057
|
1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00002057
|
1160 | CKMT2, SMTCK | creatine kinase, mitochondrial 2 (sarcomeric) (EC:2.7.3.2) |
C00002057
|
100196409 |
C00002057
|
||
1164 | CKS2, CKSHS2 | CDC28 protein kinase regulatory subunit 2 |
C00002057
|
23155 | CLCC1, MCLC | chloride channel CLIC-like 1 |
C00002057
|
1182 | CLCN3, CLC3, ClC-3 | chloride channel, voltage-sensitive 3 |
C00002057
|
1192 | CLIC1, G6, NCC27 | chloride intracellular channel 1 |
C00002057
|
1272 | CNTN1, F3, GP135 | contactin 1 |
C00002057
|
1382 | CRABP2, CRABP-II, RBP6 | cellular retinoic acid binding protein 2 |
C00002057
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002057
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00002057
|
3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 |
C00002057
|
2833 | CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR | chemokine (C-X-C motif) receptor 3 |
C00002057
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002057
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002057
|
1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00002057
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002057
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002057
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00002057
|
1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
C00002057
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002057
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00002057
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002057
|
1621 | DBH, DBM | dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1) |
C00002057
|
54876 | DCAF16, C4orf30 | DDB1 and CUL4 associated factor 16 |
C00002057
|
1642 | DDB1, DDBA, UV-DDB1, XAP1, XPCE, XPE, XPE-BF | damage-specific DNA binding protein 1, 127kDa |
C00002057
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002057
|
10521 | DDX17, P72, RH70 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 (EC:3.6.4.13) |
C00002057
|
9191 | DEDD, CASP8IP1, DEDD1, DEFT, FLDED1 | death effector domain containing |
C00002057
|
1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
C00002057
|
1719 | DHFR, DHFRP1, DYR | dihydrofolate reductase (EC:1.5.1.3) |
C00002057
|
1725 | DHPS, DHS, DS, MIG13 | deoxyhypusine synthase (EC:2.5.1.46) |
C00002057
|
1777 | DNASE2, DNASE2A, DNL, DNL2 | deoxyribonuclease II, lysosomal (EC:3.1.22.1) |
C00002057
|
10059 | DNM1L, DLP1, DRP1, DVLP, DYMPLE, EMPF, HDYNIV | dynamin 1-like (EC:3.6.5.5) |
C00002057
|
1841 | DTYMK, CDC8, PP3731, TMPK, TYMK | deoxythymidylate kinase (thymidylate kinase) (EC:2.7.4.9) |
C00002057
|
1856 | DVL2 | dishevelled segment polarity protein 2 |
C00002057
|
1783 | DYNC1LI2, DNCLI2, LIC2 | dynein, cytoplasmic 1, light intermediate chain 2 |
C00002057
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00002057
|
1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00002057
|
1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00002057
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00002057
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00002057
|
1909 | EDNRA, ET-A, ETA, ETA-R, ETAR, ETRA, hET-AR | endothelin receptor type A |
C00002057
|
1938 | EEF2, EEF-2, EF-2, EF2, SCA26 | eukaryotic translation elongation factor 2 |
C00002057
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002057
|
5610 | EIF2AK2, EIF2AK1, PKR, PRKR | eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) |
C00002057
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00002057
|
27436 | EML4, C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120 | echinoderm microtubule associated protein like 4 |
C00002057
|
2042 | EPHA3, EK4, ETK, ETK1, HEK, HEK4, TYRO4 | EPH receptor A3 (EC:2.7.10.1) |
C00002057
|
2049 | EPHB3, ETK2, HEK2, TYRO6 | EPH receptor B3 (EC:2.7.10.1) |
C00002057
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00002057
|
7430 | EZR, CVIL, CVL, VIL2 | ezrin |
C00002057
|
2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00002057
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002057
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002057
|
2195 | FAT1, CDHF7, CDHR8, FAT, ME5, hFat1 | FAT atypical cadherin 1 |
C00002057
|
9638 | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
C00002057
|
2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00002057
|
2322 | FLT3, CD135, FLK-2, FLK2, STK1 | fms-related tyrosine kinase 3 (EC:2.7.10.1) |
C00002057
|
2328 | FMO3, FMOII, TMAU, dJ127D3.1 | flavin containing monooxygenase 3 (EC:1.14.13.8 1.14.13.148) |
C00002057
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002057
|
2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00002057
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002057
|
2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00002057
|
2308 | FOXO1, FKH1, FKHR, FOXO1A | forkhead box O1 |
C00002057
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00002057
|
2582 | GALE, SDR1E1 | UDP-galactose-4-epimerase (EC:5.1.3.2) |
C00002057
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002057
|
2643 | GCH1, DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1, HPABH4B | GTP cyclohydrolase 1 (EC:3.5.4.16) |
C00002057
|
2657 | GDF1, DORV, DTGA3, RAI | growth differentiation factor 1 |
C00002057
|
11010 | GLIPR1, CRISP7, GLIPR, RTVP1 | GLI pathogenesis-related 1 |
C00002057
|
2790 | GNG10 | guanine nucleotide binding protein (G protein), gamma 10 |
C00002057
|
2803 | GOLGA4, GCP2, GOLG, MU-RMS-40.18, p230 | golgin A4 |
C00002057
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00002057
|
30206 |
C00002057
|
||
2931 | GSK3A | glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) |
C00002057
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002057
|
2978 | GUCA1A, C6orf131, COD3, CORD14, GCAP, GCAP1, GUCA, GUCA1, dJ139D8.6 | guanylate cyclase activator 1A (retina) |
C00002057
|
3094 | HINT1, HINT, NMAN, PKCI-1, PRKCNH1 | histidine triad nucleotide binding protein 1 |
C00002057
|
6596 | HLTF, HIP116, HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3, ZBU1 | helicase-like transcription factor |
C00002057
|
3159 | HMGA1, HMG-R, HMGA1A, HMGIY | high mobility group AT-hook 1 |
C00002057
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00002057
|
50809 | HP1BP3, HP1-BP74 | heterochromatin protein 1, binding protein 3 |
C00002057
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00002057
|
3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00002057
|
2537 | IFI6, 6-16, FAM14C, G1P3, IFI-6-16, IFI616 | interferon, alpha-inducible protein 6 |
C00002057
|
3454 | IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC | interferon (alpha, beta and omega) receptor 1 |
C00002057
|
3507 |
C00002057
|
||
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002057
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002057
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002057
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00002057
|
3563 | IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | interleukin 3 receptor, alpha (low affinity) |
C00002057
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002057
|
3574 | IL7, IL-7 | interleukin 7 |
C00002057
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002057
|
3578 | IL9, HP40, IL-9, P40 | interleukin 9 |
C00002057
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00002057
|
3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00002057
|
3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00002057
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00002057
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00002057
|
3713 | IVL | involucrin |
C00002057
|
80853 | KDM7A, JHDM1D | lysine (K)-specific demethylase 7A |
C00002057
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002057
|
3726 | JUNB, AP-1 | jun B proto-oncogene |
C00002057
|
8462 | KLF11, FKLF, FKLF1, MODY7, TIEG2, Tieg3 | Kruppel-like factor 11 |
C00002057
|
58508 | KMT2C, HALR, MLL3 | lysine (K)-specific methyltransferase 2C (EC:2.1.1.43) |
C00002057
|
3912 | LAMB1, CLM, LIS5 | laminin, beta 1 |
C00002057
|
3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00002057
|
3936 | LCP1, CP64, L-PLASTIN, LC64P, LPL, PLS2 | lymphocyte cytosolic protein 1 (L-plastin) |
C00002057
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002057
|
3981 | LIG4 | ligase IV, DNA, ATP-dependent (EC:6.5.1.1) |
C00002057
|
9516 | LITAF, PIG7, SIMPLE, TP53I7 | lipopolysaccharide-induced TNF factor |
C00002057
|
9208 | LRRFIP1, FLAP-1, FLAP1, FLIIAP1, GCF-2, GCF2, HUFI-1, TRIP | leucine rich repeat (in FLII) interacting protein 1 |
C00002057
|
4050 | LTB, TNFC, TNFSF3, p33 | lymphotoxin beta (TNF superfamily, member 3) |
C00002057
|
116068 | LYSMD3 | LysM, putative peptidoglycan-binding, domain containing 3 |
C00002057
|
8567 | MADD, DENN, IG20, RAB3GEP | MAP-kinase activating death domain |
C00002057
|
378938 | MALAT1, HCN, LINC00047, MALAT-1, NCRNA00047, NEAT2, PRO2853 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
C00002057
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002057
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002057
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002057
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002057
|
80306 | MED28, 1500003D12Rik, EG1, magicin | mediator complex subunit 28 |
C00002057
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00002057
|
4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00002057
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002057
|
4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00002057
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002057
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002057
|
4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) |
C00002057
|
4528 | MTIF2 | mitochondrial translational initiation factor 2 |
C00002057
|
4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
C00002057
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002057
|
4637 | MYL6, ESMLC, LC17, LC17-GI, LC17-NM, LC17A, LC17B, MLC-3, MLC1SM, MLC3NM, MLC3SM | myosin, light chain 6, alkali, smooth muscle and non-muscle |
C00002057
|
79923 | NANOG | Nanog homeobox |
C00002057
|
4698 | NDUFA5, B13, CI-13KD-B, CI-13kB, NUFM, UQOR13 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (EC:1.6.5.3 1.6.99.3) |
C00002057
|
4741 | NEFM, NEF3, NF-M, NFM | neurofilament, medium polypeptide |
C00002057
|
4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00002057
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002057
|
4794 | NFKBIE, IKBE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
C00002057
|
4801 | NFYB, CBF-A, CBF-B, HAP3, NF-YB | nuclear transcription factor Y, beta |
C00002057
|
51199 | NIN, SCKL7 | ninein (GSK3B interacting protein) |
C00002057
|
4832 | NME3, DR-nm23, NDPK-C, NDPKC, NM23-H3, NM23H3, c371H6.2 | NME/NM23 nucleoside diphosphate kinase 3 (EC:2.7.4.6) |
C00002057
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002057
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002057
|
4915 | NTRK2, GP145-TrkB, TRKB, trk-B | neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1) |
C00002057
|
8473 | OGT, HRNT1, O-GLCNAC | O-linked N-acetylglucosamine (GlcNAc) transferase (EC:2.4.1.255) |
C00002057
|
4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 |
C00002057
|
4999 | ORC2, ORC2L | origin recognition complex, subunit 2 |
C00002057
|
79646 | PANK3 | pantothenate kinase 3 (EC:2.7.1.33) |
C00002057
|
5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00002057
|
3355109 |
C00002057
|
||
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002057
|
5111 | PCNA | proliferating cell nuclear antigen |
C00002057
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00002057
|
5159 | PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1 | platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1) |
C00002057
|
51317 | PHF21A, BHC80 | PHD finger protein 21A |
C00002057
|
23469 | PHF3 | PHD finger protein 3 |
C00002057
|
35178 |
C00002057
|
||
5281 | PIGF | phosphatidylinositol glycan anchor biosynthesis, class F (EC:2.7.8.1) |
C00002057
|
5290 | PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) |
C00002057
|
5586 | PKN2, PAK2, PRK2, PRKCL2, PRO2042, Pak-2 | protein kinase N2 (EC:2.7.11.13) |
C00002057
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00002057
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00002057
|
5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00002057
|
5337 | PLD1 | phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4) |
C00002057
|
5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) |
C00002057
|
57480 | PLEKHG1, ARHGEF41 | pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
C00002057
|
5409 | PNMT, PENT, PNMTase | phenylethanolamine N-methyltransferase (EC:2.1.1.28) |
C00002057
|
8228 | PNPLA4, DXS1283E, GS2, iPLA2eta | patatin-like phospholipase domain containing 4 (EC:3.1.1.3) |
C00002057
|
5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00002057
|
5450 | POU2AF1, BOB1, OBF-1, OBF1, OCAB | POU class 2 associating factor 1 |
C00002057
|
5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00002057
|
5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00002057
|
5523 | PPP2R3A, PPP2R3, PR130, PR72 | protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16) |
C00002057
|
5577 | PRKAR2B, PRKAR2, RII-BETA | protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1) |
C00002057
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002057
|
5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00002057
|
5589 | PRKCSH, AGE-R2, G19P1, PCLD, PKCSH, PLD1 | protein kinase C substrate 80K-H (EC:2.7.11.1) |
C00002057
|
5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00002057
|
55119 | PRPF38B, NET1, RP11-293A10.1 | pre-mRNA processing factor 38B |
C00002057
|
23215 | PRRC2C, BAT2-iso, BAT2D1, BAT2L2, XTP2 | proline-rich coiled-coil 2C |
C00002057
|
5644 | PRSS1, TRP1, TRY1, TRY4, TRYP1 | protease, serine, 1 (trypsin 1) (EC:3.4.21.4) |
C00002057
|
5694 | PSMB6, DELTA, LMPY, Y | proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1) |
C00002057
|
5724 | PTAFR, PAFR | platelet-activating factor receptor |
C00002057
|
58155 | PTBP2, PTB, PTBLP, brPTB, nPTB, nPTB5, nPTB6, nPTB7, nPTB8 | polypyrimidine tract binding protein 2 |
C00002057
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002057
|
5786 | PTPRA, HEPTP, HLPR, HPTPA, HPTPalpha, LRP, PTPA, PTPRL2, R-PTP-alpha, RPTPA | protein tyrosine phosphatase, receptor type, A (EC:3.1.3.48) |
C00002057
|
5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long |
C00002057
|
5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family |
C00002057
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00002057
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00002057
|
5916 | RARG, NR1B3, RARC | retinoic acid receptor, gamma |
C00002057
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002057
|
5930 | RBBP6, MY038, P2P-R, PACT, RBQ-1, SNAMA | retinoblastoma binding protein 6 |
C00002057
|
146713 | RBFOX3, FOX-3, FOX3, HRNBP3, NEUN | RNA binding protein, fox-1 homolog (C. elegans) 3 |
C00002057
|
5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) |
C00002057
|
5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) |
C00002057
|
58517 | RBM25, NET52, RED120, RNPC7, S164, Snu71, fSAP94 | RNA binding motif protein 25 |
C00002057
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002057
|
5994 | RFXAP | regulatory factor X-associated protein |
C00002057
|
5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00002057
|
6018 | RLF, ZN-15L, ZNF292L | rearranged L-myc fusion |
C00002057
|
6130 | RPL7A, L7A, SURF3, TRUP | ribosomal protein L7a |
C00002057
|
6230 | RPS25, S25 | ribosomal protein S25 |
C00002057
|
57521 | RPTOR, KOG1, Mip1 | regulatory associated protein of MTOR, complex 1 |
C00002057
|
862 | RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
C00002057
|
6281 | S100A10, 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1], GP11, P11, p10 | S100 calcium binding protein A10 |
C00002057
|
44263 |
C00002057
|
||
66234 |
C00002057
|
||
9169 | SCAF11, CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP | SR-related CTD-associated factor 11 |
C00002057
|
23480 | SEC61G, SSS1 | Sec61 gamma subunit |
C00002057
|
10955 | SERINC3, AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 | serine incorporator 3 |
C00002057
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00002057
|
871 | SERPINH1, AsTP3, CBP1, CBP2, HSP47, OI10, PPROM, RA-A47, SERPINH2, gp46 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
C00002057
|
51639 | SF3B14, HSPC175, Ht006, P14, SAP14, SF3B14a | splicing factor 3B, 14 kDa subunit |
C00002057
|
10572 | SIVA1, CD27BP, SIVA, Siva-1, Siva-2 | SIVA1, apoptosis-inducing factor |
C00002057
|
6573 | SLC19A1, CHMD, FOLT, IFC1, REFC, RFC1 | solute carrier family 19 (folate transporter), member 1 |
C00002057
|
10559 | SLC35A1, CDG2F, CMPST, CST, hCST | solute carrier family 35 (CMP-sialic acid transporter), member A1 |
C00002057
|
25800 | SLC39A6, LIV-1 | solute carrier family 39 (zinc transporter), member 6 |
C00002057
|
9351 | SLC9A3R2, E3KARP, NHE3RF2, NHERF-2, NHERF2, OCTS2, SIP-1, SIP1, TKA-1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
C00002057
|
4093 | SMAD9, MADH6, MADH9, PPH2, SMAD8, SMAD8A, SMAD8B | SMAD family member 9 |
C00002057
|
6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 |
C00002057
|
6591 | SNAI2, SLUG, SLUGH1, SNAIL2, WS2D | snail family zinc finger 2 |
C00002057
|
6619 | SNAPC3, PTFbeta, SNAP50 | small nuclear RNA activating complex, polypeptide 3, 50kDa |
C00002057
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002057
|
252672 |
C00002057
|
||
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00002057
|
6654 | SOS1, GF1, GGF1, GINGF, HGF, NS4 | son of sevenless homolog 1 (Drosophila) |
C00002057
|
9043 | SPAG9, CT89, HLC-6, HLC4, JIP-4, JIP4, JLP, PHET, PIG6 | sperm associated antigen 9 |
C00002057
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00002057
|
6714 | SRC, ASV, SRC1, c-SRC, p60-Src | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) |
C00002057
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00002057
|
400410 | ST20, HCCS-1 | suppressor of tumorigenicity 20 |
C00002057
|
6770 | STAR, STARD1 | steroidogenic acute regulatory protein |
C00002057
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00002057
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00002057
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00002057
|
6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00002057
|
8614 | STC2, STC-2, STCRP | stanniocalcin 2 |
C00002057
|
10963 | STIP1, HOP, IEF-SSP-3521, P60, STI1, STI1L | stress-induced-phosphoprotein 1 |
C00002057
|
10494 | STK25, SOK1, YSK1 | serine/threonine kinase 25 (EC:2.7.11.1) |
C00002057
|
6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 |
C00002057
|
6827 | SUPT4H1, SPT4, SPT4H, SUPT4H | suppressor of Ty 4 homolog 1 (S. cerevisiae) |
C00002057
|
8407 | TAGLN2, HA1756 | transgelin 2 |
C00002057
|
57551 | TAOK1, KFC-B, MAP3K16, MARKK, PSK-2, PSK2, TAO1, hKFC-B, hTAOK1 | TAO kinase 1 (EC:2.7.11.1) |
C00002057
|
7027 | TFDP1, DP1, DRTF1, Dp-1 | transcription factor Dp-1 |
C00002057
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00002057
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002057
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00002057
|
9984 | THOC1, HPR1, P84, P84N5 | THO complex 1 |
C00002057
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00002057
|
7078 | TIMP3, HSMRK222, K222, K222TA2, SFD | TIMP metallopeptidase inhibitor 3 |
C00002057
|
7079 | TIMP4 | TIMP metallopeptidase inhibitor 4 |
C00002057
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00002057
|
440026 | TMEM41B | transmembrane protein 41B |
C00002057
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002057
|
7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00002057
|
11073 | TOPBP1, TOP2BP1 | topoisomerase (DNA) II binding protein 1 |
C00002057
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002057
|
7175 | TPR | translocated promoter region, nuclear basket protein |
C00002057
|
29896 | TRA2A, AWMS1, HSU53209 | transformer 2 alpha homolog (Drosophila) |
C00002057
|
28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00002057
|
9321 | TRIP11, ACG1A, CEV14, GMAP-210, TRIP-11, TRIP230 | thyroid hormone receptor interactor 11 |
C00002057
|
7253 | TSHR, CHNG1, LGR3, hTSHR-I | thyroid stimulating hormone receptor |
C00002057
|
7277 | TUBA4A, H2-ALPHA, TUBA1 | tubulin, alpha 4a |
C00002057
|
203068 | TUBB, M40, OK/SW-cl.56, TUBB1, TUBB5 | tubulin, beta class I |
C00002057
|
7291 | TWIST1, ACS3, BPES2, BPES3, CRS1, SCS, TWIST, bHLHa38 | twist family bHLH transcription factor 1 |
C00002057
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00002057
|
23350 | U2SURP, SR140, fSAPa | U2 snRNP-associated SURP domain containing |
C00002057
|
10054 | UBA2, ARX, SAE2 | ubiquitin-like modifier activating enzyme 2 |
C00002057
|
11065 | UBE2C, UBCH10, dJ447F3.2 | ubiquitin-conjugating enzyme E2C (EC:6.3.2.19) |
C00002057
|
7329 | UBE2I, C358B7.1, P18, UBC9 | ubiquitin-conjugating enzyme E2I (EC:6.3.2.19) |
C00002057
|
7337 | UBE3A, ANCR, AS, E6-AP, EPVE6AP, HPVE6A | ubiquitin protein ligase E3A (EC:6.3.2.19) |
C00002057
|
51569 | UFM1, BM-002, C13orf20 | ubiquitin-fold modifier 1 |
C00002057
|
7360 | UGP2, UDPG, UDPGP, UDPGP2, UGP1, UGPP1, UGPP2, pHC379 | UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) |
C00002057
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002057
|
54657 | UGT1A4, HUG-BR2, UDPGT, UDPGT_1-4, UGT-1D, UGT1-04, UGT1.4, UGT1D | UDP glucuronosyltransferase 1 family, polypeptide A4 (EC:2.4.1.17) |
C00002057
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002057
|
9094 | UNC119, HRG4, POC7, POC7A | unc-119 homolog (C. elegans) |
C00002057
|
7386 | UQCRFS1, RIP1, RIS1, RISP, UQCR5 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (EC:1.10.2.2) |
C00002057
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002057
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002057
|
7431 | VIM, CTRCT30 | vimentin |
C00002057
|
7450 | VWF, F8VWF, VWD | von Willebrand factor |
C00002057
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002057
|
7503 | XIST, DXS1089, DXS399E, LINC00001, NCRNA00001, SXI1, swd66 | X inactive specific transcript (non-protein coding) |
C00002057
|
7525 | YES1, HsT441, P61-YES, Yes, c-yes | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 (EC:2.7.10.2) |
C00002057
|
23318 | ZCCHC11, PAPD3, TUT4 | zinc finger, CCHC domain containing 11 (EC:2.7.7.52) |
C00002057
|
84240 | ZCCHC9, PPP1R41 | zinc finger, CCHC domain containing 9 |
C00002057
|
6935 | ZEB1, AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3, TCF8, ZFHEP, ZFHX1A | zinc finger E-box binding homeobox 1 |
C00002057
|
7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00002057
|
51663 | ZFR, ZFR1 | zinc finger RNA binding protein |
C00002057
|
23613 | ZMYND8, PRKCBP1, PRO2893, RACK7 | zinc finger, MYND-type containing 8 |
C00002057
|
7705 | ZNF146, OZF | zinc finger protein 146 |
C00002057
|
100129482 | ZNF37BP, KOX21, ZNF37B | zinc finger protein 37B, pseudogene |
C00002057
|
90333 | ZNF468 | zinc finger protein 468 |
C00002057
|
100289635 | ZNF605 | zinc finger protein 605 |
C00002057
|
100129842 | ZNF737, ZNF102 | zinc finger protein 737 |
C00002057
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#212140 | Carnitine deficiency, systemic primary; cdsp |
O76082
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#265000 | Multiple pterygium syndrome, escobar variant; evmps |
P07510
|
#253290 | Multiple pterygium syndrome, lethal type; lmps |
P02708
P07510 Q07001 |
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency |
P11230
|
#608930 | Myasthenic syndrome, congenital, fast-channel |
P02708
Q07001 |
#601462 | Myasthenic syndrome, congenital, slow-channel; sccms |
P02708
P11230 Q07001 |
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180300 | Rheumatoid arthritis; ra |
Q9H015
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P30532
P32297 |
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00286 | Crohn's disease |
O76082
(related)
Q9H015 (related) |
H00525 | Disorders of fatty-acid oxidation |
O76082
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00770 | Congenital myasthenic syndrome |
P02708
(related)
P11230 (related) Q07001 (related) |
H00986 | Multiple pterygium syndrome |
P02708
(related)
P07510 (related) Q07001 (related) |
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006948 | Hyperkinesis |
C00002017
C00002015 C00002057 |
D001259 | Ataxia |
C00002015
C00002057 |
D014202 | Tremor |
C00002015
C00002057 |
D011297 | Prenatal Exposure Delayed Effects |
C00002057
|
D015746 | Abdominal Pain |
C00002057
|
D000014 | Abnormalities, Drug-Induced |
C00002057
|
D058186 | Acute Kidney Injury |
C00002057
|
D000405 | Akinetic Mutism |
C00002057
|
D000437 | Alcoholism |
C00002057
|
D000544 | Alzheimer Disease |
C00002057
|
D000647 | Amnesia |
C00002057
|
D019969 | Amphetamine-Related Disorders |
C00002057
|
D017542 | Aneurysm, Ruptured |
C00002057
|
D000860 | Anoxia |
C00002057
|
D001008 | Anxiety Disorders |
C00002057
|
D001014 | Aortic Aneurysm |
C00002057
|
D001018 | Aortic Diseases |
C00002057
|
D001049 | Apnea |
C00002057
|
D001145 | Arrhythmias, Cardiac |
C00002057
|
D001161 | Arteriosclerosis |
C00002057
|
D001168 | Arthritis |
C00002057
|
D001176 | Arthrogryposis |
C00002057
|
D050197 | Atherosclerosis |
C00002057
|
D001281 | Atrial Fibrillation |
C00002057
|
D054537 | Atrioventricular Block |
C00002057
|
D001289 | Attention Deficit Disorder with Hyperactivity |
C00002057
|
D001308 | Auditory Perceptual Disorders |
C00002057
|
D001714 | Bipolar Disorder |
C00002057
|
D001919 | Bradycardia |
C00002057
|
D001927 | Brain Diseases |
C00002057
|
D001929 | Brain Edema |
C00002057
|
D001930 | Brain Injuries |
C00002057
|
D001943 | Breast Neoplasms |
C00002057
|
D002114 | Calcinosis |
C00002057
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00002057
|
D002294 | Carcinoma, Squamous Cell |
C00002057
|
D005117 | Cardiac Complexes, Premature |
C00002057
|
D009202 | Cardiomyopathies |
C00002057
|
D002318 | Cardiovascular Diseases |
C00002057
|
D002375 | Catalepsy |
C00002057
|
D002543 | Cerebral Hemorrhage |
C00002057
|
D002561 | Cerebrovascular Disorders |
C00002057
|
D018290 | Cervical Intraepithelial Neoplasia |
C00002057
|
D002637 | Chest Pain |
C00002057
|
D019970 | Cocaine-Related Disorders |
C00002057
|
D003072 | Cognition Disorders |
C00002057
|
D003093 | Colitis, Ulcerative |
C00002057
|
D003110 | Colonic Neoplasms |
C00002057
|
D019955 | Conduct Disorder |
C00002057
|
D003251 | Constriction, Pathologic |
C00002057
|
D003324 | Coronary Artery Disease |
C00002057
|
D003329 | Coronary Vasospasm |
C00002057
|
D003490 | Cyanosis |
C00002057
|
D003693 | Delirium |
C00002057
|
D003866 | Depressive Disorder |
C00002057
|
D003865 | Depressive Disorder, Major |
C00002057
|
D003872 | Dermatitis |
C00002057
|
D003924 | Diabetes Mellitus, Type 2 |
C00002057
|
D003928 | Diabetic Nephropathies |
C00002057
|
D003967 | Diarrhea |
C00002057
|
D004244 | Dizziness |
C00002057
|
D056486 | Drug-Induced Liver Injury |
C00002057
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00002057
|
D004409 | Dyskinesia, Drug-Induced |
C00002057
|
D004421 | Dystonia |
C00002057
|
D020821 | Dystonic Disorders |
C00002057
|
D001068 | Eating Disorders |
C00002057
|
D004487 | Edema |
C00002057
|
D004802 | Eosinophilia |
C00002057
|
D007172 | Erectile Dysfunction |
C00002057
|
D004890 | Erythema |
C00002057
|
D005076 | Exanthema |
C00002057
|
D005234 | Fatty Liver |
C00002057
|
D005317 | Fetal Growth Retardation |
C00002057
|
D005334 | Fever |
C00002057
|
D005921 | Glomerulonephritis |
C00002057
|
D044882 | Glucose Metabolism Disorders |
C00002057
|
D006261 | Headache |
C00002057
|
D006258 | Head and Neck Neoplasms |
C00002057
|
D006323 | Heart Arrest |
C00002057
|
D006606 | Hiccup |
C00002057
|
D006930 | Hyperalgesia |
C00002057
|
D006940 | Hyperemia |
C00002057
|
D006973 | Hypertension |
C00002057
|
D006976 | Hypertension, Pulmonary |
C00002057
|
D006984 | Hypertrophy |
C00002057
|
D006985 | Hyperventilation |
C00002057
|
D018476 | Hypokinesia |
C00002057
|
D007022 | Hypotension |
C00002057
|
D007035 | Hypothermia |
C00002057
|
D007246 | Infertility |
C00002057
|
D007249 | Inflammation |
C00002057
|
D007333 | Insulin Resistance |
C00002057
|
D055959 | Intervertebral Disc Degeneration |
C00002057
|
D002542 | Intracranial Embolism and Thrombosis |
C00002057
|
D007511 | Ischemia |
C00002057
|
D007805 | Language Development Disorders |
C00002057
|
D007859 | Learning Disorders |
C00002057
|
D008107 | Liver Diseases |
C00002057
|
D008133 | Long QT Syndrome |
C00002057
|
D008171 | Lung Diseases |
C00002057
|
D008175 | Lung Neoplasms |
C00002057
|
D008545 | Melanoma |
C00002057
|
D008569 | Memory Disorders |
C00002057
|
D028361 | Mitochondrial Diseases |
C00002057
|
D009041 | Motion Sickness |
C00002057
|
D009069 | Movement Disorders |
C00002057
|
D020267 | MPTP Poisoning |
C00002057
|
D009133 | Muscular Atrophy |
C00002057
|
D009203 | Myocardial Infarction |
C00002057
|
D015428 | Myocardial Reperfusion Injury |
C00002057
|
D009207 | Myoclonus |
C00002057
|
D009325 | Nausea |
C00002057
|
D009336 | Necrosis |
C00002057
|
D009361 | Neoplasm Invasiveness |
C00002057
|
D009362 | Neoplasm Metastasis |
C00002057
|
D009369 | Neoplasms |
C00002057
|
D009374 | Neoplasms, Experimental |
C00002057
|
D009389 | Neovascularization, Pathologic |
C00002057
|
D009410 | Nerve Degeneration |
C00002057
|
D009422 | Nervous System Diseases |
C00002057
|
D009436 | Neural Tube Defects |
C00002057
|
D019954 | Neurobehavioral Manifestations |
C00002057
|
D019636 | Neurodegenerative Diseases |
C00002057
|
D054081 | Neuronal Migration Disorders |
C00002057
|
D020258 | Neurotoxicity Syndromes |
C00002057
|
D009669 | Nose Neoplasms |
C00002057
|
D009759 | Nystagmus, Pathologic |
C00002057
|
D009765 | Obesity |
C00002057
|
D009845 | Oligospermia |
C00002057
|
D010146 | Pain |
C00002057
|
D010182 | Pancreatic Diseases |
C00002057
|
D010190 | Pancreatic Neoplasms |
C00002057
|
D016584 | Panic Disorder |
C00002057
|
D030361 | Papillomavirus Infections |
C00002057
|
D010243 | Paralysis |
C00002057
|
D010291 | Paresis |
C00002057
|
D010302 | Parkinson Disease, Secondary |
C00002057
|
D010510 | Periodontal Diseases |
C00002057
|
D010523 | Peripheral Nervous System Diseases |
C00002057
|
D016491 | Peripheral Vascular Diseases |
C00002057
|
D011041 | Poisoning |
C00002057
|
D011086 | Polycythemia |
C00002057
|
D011183 | Postoperative Complications |
C00002057
|
D018908 | Muscle Weakness |
C00002015
|
D003668 | Pressure Ulcer |
C00002057
|
D011507 | Proteinuria |
C00002057
|
D011537 | Pruritus |
C00002057
|
D011605 | Psychoses, Substance-Induced |
C00002057
|
D011618 | Psychotic Disorders |
C00002057
|
D011654 | Pulmonary Edema |
C00002057
|
D011693 | Purpura |
C00002057
|
D012021 | Reflex, Abnormal |
C00002057
|
D051436 | Renal Insufficiency, Chronic |
C00002057
|
D015427 | Reperfusion Injury |
C00002057
|
D012120 | Respiration Disorders |
C00002057
|
D012131 | Respiratory Insufficiency |
C00002057
|
D015619 | Respiratory System Abnormalities |
C00002057
|
D012164 | Retinal Diseases |
C00002057
|
D012640 | Seizures |
C00002057
|
D012798 | Sialorrhea |
C00002057
|
D012848 | Sinoatrial Block |
C00002057
|
D012878 | Skin Neoplasms |
C00002057
|
D012893 | Sleep Disorders |
C00002057
|
D007319 | Sleep Initiation and Maintenance Disorders |
C00002057
|
D055752 | Small Cell Lung Carcinoma |
C00002057
|
D013035 | Spasm |
C00002057
|
D016137 | Spina Bifida Cystica |
C00002057
|
D013117 | Spinal Cord Compression |
C00002057
|
D019956 | Stereotypic Movement Disorder |
C00002057
|
D013274 | Stomach Neoplasms |
C00002057
|
D013276 | Stomach Ulcer |
C00002057
|
D020521 | Stroke |
C00002057
|
D013345 | Subarachnoid Hemorrhage |
C00002057
|
D019966 | Substance-Related Disorders |
C00002057
|
D013375 | Substance Withdrawal Syndrome |
C00002057
|
D013398 | Sudden Infant Death |
C00002057
|
D013610 | Tachycardia |
C00002057
|
D013919 | Thromboangiitis Obliterans |
C00002057
|
D013927 | Thrombosis |
C00002057
|
D020323 | Tics |
C00002057
|
188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO |
C00002057
|
D014029 | Tobacco Use Disorder |
C00002057
|
D005879 | Tourette Syndrome |
C00002057
|
D014133 | Tracheal Diseases |
C00002057
|
D001745 | Urinary Bladder Diseases |
C00002057
|
D014652 | Vascular Diseases |
C00002057
|
D014657 | Vasculitis |
C00002057
|
D018366 | Vasculitis, Leukocytoclastic, Cutaneous |
C00002057
|
D018879 | Ventricular Premature Complexes |
C00002057
|
D014839 | Vomiting |
C00002057
|
D015430 | Weight Gain |
C00002057
|